Author:
Locatelli M.C.,D'Antona A.,Luporini G.
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference42 articles.
1. Gralla RJ, Itri LD, Pils SE et al. Antiemetic efficacy of high-dose metoclopramide: randomised trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305: 905–909.
2. Kris MG, Gralla RJ, Clark RA et al. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Cancer Treat Rep 1985; 69: 1257–1262.
3. Aapro MS. Controlling emesis related to cancer therapy. Eur J Cancer 1991; 27(3): 356–361.
4. McRitchie B, McClelland CM, Cooper SM et al. Dopamine antagonists as antiemetics and as stimulants of gastric motility. In: Benett A, Velo G, eds, Mechanisms of Gastrointestinal Motility and Secretion, New York, Plenum 1984; 287–301.
5. Fozard JR. Neuronal 5-HT receptors in the periphery. Neuropharmacology 1984; 23: 1473–1486.